Publications in collaboration with researchers from Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (26)

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  3. Differential mitochondrial adaptation and FNDC5 production in brown and white adipose tissue in response to cold and obesity

    Obesity, Vol. 32, Núm. 11, pp. 2120-2134

  4. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  5. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  6. Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study: Glucometrics knowledge and glycemic control in type 1 diabetes.

    Diabetes and Metabolism

  7. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

    Journal of Physiology and Biochemistry

  8. Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease

    Nefrologia, Vol. 44, Núm. 5, pp. 678-688

  9. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 4, pp. 1157-1170

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Antidiabetic Drugs That Reduce Weight and Are Cardioprotective

    Handbook of Obesity - Volume 2: Clinical Applications, Fifth Edition (CRC Press), pp. 318-332

  3. BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  4. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  5. Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors

    Nutrients, Vol. 15, Núm. 22

  6. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Association between Circulating Levels of 25-Hydroxyvitamin D3 and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes

    Nutrients, Vol. 14, Núm. 17

  2. Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease

    Frontiers in Medicine, Vol. 9

  3. Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  4. Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance

    Nutrients, Vol. 14, Núm. 20

  5. Prevention of Cardiorenal Complications with Sodium–Glucose Cotransporter Type 2 Inhibitors: A Narrative Review

    Diabetes Therapy, Vol. 13, pp. 5-17